| Analysis | Metabolite Name | Measured Value | Units | Model | Intervention |
|---|---|---|---|---|---|
| Normal phase UNSPECIFIED ION MODE | Lauroylcarnitine | 0.000032 | peak area | Alzheimer’s disease model | Saline |
| Normal phase UNSPECIFIED ION MODE | Lauroylcarnitine | 0.000033 | peak area | Alzheimer’s disease model | Saline |
| Normal phase UNSPECIFIED ION MODE | Lauroylcarnitine | 0.000040 | peak area | Alzheimer’s disease model | B. breve MCC1274 |
| Normal phase UNSPECIFIED ION MODE | Lauroylcarnitine | 0.000067 | peak area | Alzheimer’s disease model | Saline |
| Normal phase UNSPECIFIED ION MODE | Lauroylcarnitine | 0.000071 | peak area | Wild type | Saline |
| Normal phase UNSPECIFIED ION MODE | Lauroylcarnitine | 0.000072 | peak area | Alzheimer’s disease model | B. breve MCC1274 |
| Normal phase UNSPECIFIED ION MODE | Lauroylcarnitine | 0.000073 | peak area | Wild type | Saline |
| Normal phase UNSPECIFIED ION MODE | Lauroylcarnitine | 0.000081 | peak area | Wild type | B. breve MCC1274 |
| Normal phase UNSPECIFIED ION MODE | Lauroylcarnitine | 0.000082 | peak area | Wild type | Saline |
| Normal phase UNSPECIFIED ION MODE | Lauroylcarnitine | 0.000084 | peak area | Wild type | B. breve MCC1274 |
| Normal phase UNSPECIFIED ION MODE | Lauroylcarnitine | 0.000088 | peak area | Alzheimer’s disease model | B. breve MCC1274 |
| Normal phase UNSPECIFIED ION MODE | Lauroylcarnitine | 0.000091 | peak area | Wild type | B. breve MCC1274 |
| Normal phase UNSPECIFIED ION MODE | Lauroylcarnitine | 0.000098 | peak area | Alzheimer’s disease model | Saline |
| Normal phase UNSPECIFIED ION MODE | Lauroylcarnitine | 0.00012 | peak area | Wild type | B. breve MCC1274 |
| Normal phase UNSPECIFIED ION MODE | Lauroylcarnitine | 0.00013 | peak area | Alzheimer’s disease model | B. breve MCC1274 |
| Normal phase UNSPECIFIED ION MODE | Lauroylcarnitine | 0.00013 | peak area | Wild type | Saline |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|